Allicin was weakly reactive in the Fe(III)phenanthroline reduction assay, though quite reactive in the ORAC assay
In combination, the paired vials allow investigators to run parallel or comparative experiments that distinguish actin/cytoskeleton-focused responses (often linked to the TB500/TB4 literature) from broader tissue-response and barrier-related signaling patterns discussed in the BPC-157 preclinical literature
It not only induces breakdown of the existing BBB, but also promotes the growth of structurally altered capillaries (abnormal expression of transporters and receptors) to meet the high metabolic demand of the tumor (Mo et al., 2021)
Site choice may depend on the treatment goal, tissue condition, patient comfort, and clinical judgment
Shanbhag ST, Choong B, Petrov M, Delahunt B, Windsor JA, Phillips A